INCB3284

DB05130ExperimentalSmall molecule

INCB3284 is a CCR2 antagonist for Inflammation-driven Diseases.

Primary indication: Investigated for use/treatment in inflammatory disorders (unspecified).Curator reviewed
Code names: INCB3284

Resolves to

Compound

Targets

What you can answer from here — as of April 02, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

Which drugs share a target with INCB3284, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.